exo-cd24
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 25, 2020 (NCT04747574)
Timeline
Indications
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05947747 | Phase 2 | Jul 4, 2023 | Nano24med |
| NCT04747574 | Phase 1 | Sep 25, 2020 | Tel Aviv University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Nano24med | For profit | 1 | 1 | 1 | 2023 |
| Tel Aviv University | Academic/Hospital | 1 | 1 | 1 | 2020 |
2 organizations
Page 1 / 1